Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6469]

UT Southwestern develops test to predict immunotherapy response in kidney cancer

UT Southwestern develops test to predict immunotherapy response in kidney cancer

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

Immune cells determine how fast certain tumours grow

Immune cells determine how fast certain tumours grow

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open surgery

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open...

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung cancer

ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung...

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

Patterns of chronic lymphocytic leukaemia growth identified

Patterns of chronic lymphocytic leukaemia growth identified

More from ecancer